PET studies in progressive supranuclear palsy
- 1 January 1994
- book chapter
- Published by Springer Nature
- Vol. 42, 119-134
- https://doi.org/10.1007/978-3-7091-6641-3_10
Abstract
Functional imaging (PET and SPECT) can be used to noninvasively demonstrate the patterns of metabolic and dopaminergic dysfunction associated with progressive supranuclear palsy. In this chapter the findings of published functional imaging studies are reviewed and the value of PET for distinguishing between the various degenerative causes of parkinsonism is discussed.Keywords
This publication has 48 references indexed in Scilit:
- Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomographyAnnals of Neurology, 1992
- Corticobasal degeneration: Decreased and asymmetrical glucose consumption as studied with PETMovement Disorders, 1992
- Positron Emission Tomography in Progressive Supranuclear PalsyArchives of Neurology, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- Positron Emission Tomography Study in Progressive Supranuclear PalsyArchives of Neurology, 1990
- Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiologyBrain Research, 1989
- Loss of Striatal [76Br]Bromospiperone Binding Sites Demonstrated by Positron Tomography in Progressive Supranuclear PalsyJournal of Cerebral Blood Flow & Metabolism, 1986
- Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and CortexAnnual Review of Neuroscience, 1986
- [3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsyEuropean Journal of Pharmacology, 1984